Picture of Xbrane Biopharma AB logo

XBRANE — Xbrane Biopharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Xbrane Biopharma AB - Q1 Loss For Period Was Sek 51.3 mln

May 6 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * XBRANE BIOPHARMA AB - Q1 EBITDA WAS SEK -49.0M (-50.0*)
    * XBRANE BIOPHARMA AB - Q1 REVENUE AMOUNTED TO SEK 0M (0).
    * XBRANE BIOPHARMA AB - Q1 LOSS FOR PERIOD WAS SEK 51.3M (-51.8*).

Source text for Eikon:  ID:nMFN4fF6q7 
Further company coverage:  XBRANE.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Xbrane Biopharma AB

See all news